Log In
Print
BCIQ
Print
Print this Print this
 

ARC2172 (NU172)

  Manage Alerts
Collapse Summary General Information
Company Archemix Corp.
DescriptionDirect thrombin inhibitor (DTI)
Molecular Target Thrombin (Factor IIa) (F2)
Mechanism of ActionThrombin inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationBlock coagulation
Indication DetailsBlock coagulation in patients undergoing off-pump CABG surgery; Short acting anticoagulant during medical procedures
Regulatory Designation

Partner

Arca biopharma Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today